Cara Therapeutics
CARA
$0.79
Share price
5.84%
Change (1 day)
-79.05%
Change (1 year)
Categories
Market capitalization of Cara Therapeutics (CARA)
Market cap: $43.4 Million
As of May 2024 Cara Therapeutics has a market cap of $43.4 Million. This makes Cara Therapeutics the world's 7813th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cara Therapeutics from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $43.4 M | 7.23% |
| 2023 | $40.47 M | -92.99% |
| 2022 | $0.57 B | -11.37% |
| 2021 | $0.65 B | -13.64% |
| 2020 | $0.75 B | 0.17% |
| 2019 | $0.75 B | 46.4% |
| 2018 | $0.51 B | 28.81% |
| 2017 | $0.39 B | 57.47% |
| 2016 | $0.25 B | -44.84% |
| 2015 | $0.45 B | 102.13% |
| 2014 | $0.22 B |
End of Day market cap according to different sources
On May 19th, 2024 the market cap of Cara Therapeutics was reported to be:
$41.01 Million
$41.01 Million
$41.01 Million
$41.01 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $366.98 B | 845,340.35% | 🇺🇸 USA |
 Pfizer PFE | $162.51 B | 374,302.23% | 🇺🇸 USA |
 Trevena TRVN | $7.42 M | -82.90% | 🇺🇸 USA |
 Recro Pharma
REPH | $0.12 B | 183.90% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | $0.45 B | 957.27% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -98.11% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $14.57 M | -66.41% | 🇺🇸 USA |